✦ LIBER ✦

Clinical trials and statistical analyses: what should dermatologists look for in a report?

✍ Scribed by Mohamed Alosh; Kathleen Fritsch; Mat Soukup; Jonathan Wilkin

Book ID: 109115991
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 56 KB
Volume: 22
Category: Article
ISSN: 1396-0296
DOI: 10.1111/j.1529-8019.2009.01232.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Rasch measurement model in rheumatol

The Rasch measurement model in rheumatology: What is it and why use it? When should it be applied, and what should one look for in a Rasch paper?

✍ Tennant, Alan ;Conaghan, Philip G. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

Methodological and statistical issues of

Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshop

✍ N Neymark; W Kiebert; K Torfs; L Davies; P Fayers; B Hillner; R Gelber; G Guyatt 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Patient heterogeneity and allocation bia

Patient heterogeneity and allocation bias: how should they be reported in clinical trials of chemotherapy for advanced gastric cancer?

✍ Ichinosuke Hyodo 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 99 KB

Reporting outcomes in clinical trials fo

Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change

✍ Anabel Martinez-Arán; Eduard Vieta; KN Roy Chengappa; Samuel Gershon; Jamie Mull 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

A New Statistical Method for Dose-Findin

A New Statistical Method for Dose-Finding Based on Efficacy and Toxicity in Early Phase Clinical Trials

✍ Peter F. Thall; Elihu H. Estey; Hsi-Guang Sung 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 115 KB

SUMMARY MEASURES AND STATISTICS FOR COMP

SUMMARY MEASURES AND STATISTICS FOR COMPARISON OF QUALITY OF LIFE IN A CLINICAL TRIAL OF CANCER THERAPY

✍ DIANE L. FAIRCLOUGH 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 3 views

Assessment of health related quality of life (QOL) has become an important endpoint in many clinical trials of cancer therapy. Most of these studies entail multiple QOL scales that are assessed repeatedly over time. As a result, the problem of multiple comparisons is a primary analytic challenge wit